Singapore, June 25 -- US-based Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, has announced that the HD-XSimoa Immunoassay Analyser has received Class 1 Medical Device registration by the Ministry of Food and Drug Safety (MFDS) in South Korea through its regional distribution partner, HS Biosystems.

The continued expansion of the industry-leading Simoa(R) technology platform into global markets demonstrates a key milestone in broadening validation of biomarker-based testing and providing clinicians with minimally invasive tools that can help enhance diagnostic accuracy and improve accessibility.

Through its unparalleled sensitivity and multi-marker testing capability, the Simoa ...